RNA replicon delivery via lipid-complexed PRINT protein particles

Molecular Pharmaceutics

Volumn 10, Issue 9, 2013, Pages 3366-3374

  Xu, Jing ^d   Luft, J Christopher ^a,c,d   Yi, Xianwen ^d   Tian, Shaomin ^a,d   Owens, Gary ^e   Wang, Jin ^d,i   Johnson, Ashley ^d,h   Berglund, Peter ^e   Smith, Jonathan ^e   Napier, Mary E ^a,b,d   DeSimone, Joseph M ^a,b,c,d,f,g  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e Liquidia Technologies   (United States)

^f North Carolina State University   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h NORTH CAROLINA STATE UNIVERSITY   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

gene delivery; lipid; PRINT; protein particle; RNA replicon

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; BOVINE SERUM ALBUMIN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; RNA VACCINE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; DRUG DELIVERY SYSTEM; PARTICLE REPLICATION IN NONWETTING TEMPLATES; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN SYNTHESIS; REPLICON; VERO CELL;

CELL LINE; FATTY ACIDS, MONOUNSATURATED; GENE TRANSFER TECHNIQUES; HUMANS; LIPIDS; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; RNA; SERUM ALBUMIN, BOVINE;

EID: 84883573474     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400190z     Document Type: Article

References (41)

1. Tang, D. C.; DeVit, M.; Johnston, S. A. Genetic immunization is a simple method for eliciting an immune response Nature 1992, 356 (6365) 152-4
2. Weide, B.; Garbe, C.; Rammensee, H.-G.; Pascolo, S. Plasmid DNA- and messenger RNA-based anti-cancer vaccination Immunol. Lett. 2008, 115 (1) 33-42
3. Bringmann, A.; Held, S. A. E.; Heine, A.; Brossart, P. RNA Vaccines in Cancer Treatment J. Biomed. Biotechnol. 2010, 2010, 1-13
4. Kutzler, M. A.; Weiner, D. B. DNA vaccines: ready for prime time? Nat. Rev. Genet. 2008, 9 (10) 776-88
5. Cannon, G.; Weissman, D. RNA based vaccines DNA Cell Biol. 2002, 21 (12) 953-61
6. Vajdy, M.; Srivastava, I.; Polo, J.; Donnelly, J.; O'Hagan, D.; Singh, M. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines Immunol. Cell Biol. 2004, 82 (6) 617-27
7. Wolff, J. A.; Malone, R. W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgner, P. L. Direct gene transfer into mouse muscle in vivo Science 1990, 247 (4949 Part 1) 1465-8
8. Van Tendeloo, V. F.; Ponsaerts, P.; Lardon, F.; Nijs, G.; Lenjou, M.; Van Broeckhoven, C.; Van Bockstaele, D. R.; Berneman, Z. N. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 2001, 98 (1) 49-56
9. Lu, D.; Benjamin, R.; Kim, M.; Conry, R. M.; Curiel, D. T. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors Cancer Gene Ther. 1994, 1 (4) 245-52
10. Eisele, K.; Gropeanu, R. A.; Zehendner, C. M.; Rouhanipour, A.; Ramanathan, A.; Mihov, G.; Koynov, K.; Kuhlmann, C. R.; Vasudevan, S. G.; Luhmann, H. J.; Weil, T. Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147 Biomaterials 2010, 31 (33) 8789-801
11. Su, X.; Fricke, J.; Kavanagh, D. G.; Irvine, D. J. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles Mol. Pharmaceutics 2011, 8 (3) 774-87
12. Yamamoto, A.; Kormann, M.; Rosenecker, J.; Rudolph, C. Current prospects for mRNA gene delivery Eur. J. Pharm. Biopharm. 2009, 71 (3) 484-9
13. Zimmer, G. RNA Replicons-A New Approach for Influenza Virus Immunoprophylaxis Viruses 2010, 2 (2) 413-34
14. Anraku, I.; Harvey, T. J.; Linedale, R.; Gardner, J.; Harrich, D.; Suhrbier, A.; Khromykh, A. A. Kunjin Virus Replicon Vaccine Vectors Induce Protective CD8+ T-Cell Immunity J. Virol. 2002, 76 (8) 3791-9
15. Tannis, L.; Gauthier, A.; Evelegh, C.; Parsons, R.; Nyholt, D.; Khromykh, A.; Bramson, J. Semliki Forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity Vaccine 2005, 23 (33) 4189-94
16. Ying, H.; Zaks, T. Z.; Wang, R. F.; Irvine, K. R.; Kammula, U. S.; Marincola, F. M.; Leitner, W. W.; Restifo, N. P. Cancer therapy using a self-replicating RNA vaccine Nat. Med. 1999, 5 (7) 823-7
17. Diken, M.; Kreiter, S.; Selmi, A.; Britten, C. M.; Huber, C.; Türeci, Ö.; Sahin, U. Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation Gene Ther. 2011, 18 (7) 702-8
18. Lechardeur, D.; Sohn, K. J.; Haardt, M.; Joshi, P. B.; Monck, M.; Graham, R. W.; Beatty, B.; Squire, J.; O'Brodovich, H.; Lukacs, G. L. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer Gene Ther. 1999, 6 (4) 482-97
19. Nishimura, K.; Segawa, H.; Goto, T.; Morishita, M.; Masago, A.; Takahashi, H.; Ohmiya, Y.; Sakaguchi, T.; Asada, M.; Imamura, T.; Shimotono, K.; Takayama, K.; Yoshida, T.; Nakanishi, M. Persistent and Stable Gene Expression by a Cytoplasmic RNA Replicon Based on a Noncytopathic Variant Sendai Virus J. Biol. Chem. 2007, 282 (37) 27383-91
20. Smerdou, C.; Liljestrom, P. Non-viral amplification systems for gene transfer: vectors based on alphaviruses Curr. Opin. Mol. Ther. 1999, 1 (2) 244-51
21. Wang, Z.; Troilo, P. J.; Wang, X.; Griffiths, T. G.; Pacchione, S. J.; Barnum, A. B.; Harper, L. B.; Pauley, C. J.; Niu, Z.; Denisova, L.; Follmer, T. T.; Rizzuto, G.; Ciliberto, G.; Fattori, E.; Monica, N. L.; Manam, S.; Ledwith, B. J. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation Gene Ther. 2004, 11 (8) 711-21
22. Kofler, R. M. Mimicking live flavivirus immunization with a noninfectious RNA vaccine Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (7) 1951-6
23. Grgacic, E. V. L; Anderson, D. A. Virus-like particles: Passport to immune recognition Methods 2006, 40 (1) 60-5
24. Ramsey, J. D.; Vu, H. N.; Pack, D. W. A top-down approach for construction of hybrid polymer-virus gene delivery vectors J. Controlled Release 2010, 144 (1) 39-45
25. Geall, A. J.; Verma, A.; Otten, G. R.; Shaw, C. A.; Hekele, A.; Banerjee, K.; Cu, Y.; Beard, C. W.; Brito, L. A.; Krucker, T.; O'Hagan, D. T.; Singh, M.; Mason, P. W.; Valiante, N. M.; Dormitzer, P. R.; Barnett, S. W.; Rappuoli, R.; Ulmer, J. B.; Mandl, C. W. Nonviral delivery of self-amplifying RNA vaccines Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (36) 14604-9
26. Xu, J.; Wang, J.; Luft, J. C.; Tian, S.; Owens, G., Jr.; Pandya, A. A.; Berglund, P.; Pohlhaus, P.; Maynor, B. W.; Smith, J.; Hubby, B.; Napier, M. E.; DeSimone, J. M. Rendering protein-based particles transiently insoluble for therapeutic applications J. Am. Chem. Soc. 2012, 134 (21) 8774-7
27. Saito, G.; Swanson, J. A.; Lee, K.-D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv. Drug Delivery Rev. 2003, 55, 199-215
28. Gratton, S. E. A.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (33) 11613-8
29. Bettinger, T.; Carlisle, R. C.; Read, M. L.; Ogris, M.; Seymour, L. W. Peptide-mediated RNA delivery: A novel approach for enhanced transfection of primary and post-mitotic cells Nucleic Acids Res. 2001, 29, 3882-91
30. Hasan, W.; Chu, K.; Gullapalli, A.; Dunn, S. S.; Enlow, E. M.; Luft, J. C.; Tian, S.; Napier, M. E.; Pohlhaus, P. D.; Rolland, J. P.; DeSimone, J. M. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer Nano Lett. 2012, 12 (1) 287-92
31. Wei, C. J.; Yassine, H. M.; McTamney, P. M.; Gall, J. G.; Whittle, J. R.; Boyington, J. C.; Nabel, G. J. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure Sci. Transl. Med. 2012, 4 (147) 147ra114
32. Wang, J.; Tian, S.; Petros, R. A.; Napier, M. E.; Desimone, J. M. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies J. Am. Chem. Soc. 2010, 132 (32) 11306-13
33. Enlow, E. M.; Luft, J. C.; Napier, M. E.; DeSimone, J. M. Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic Loadings Nano Lett. 2011, 11 (2) 808-13
34. Kelly, J. Y.; DeSimone, J. M. Shape-specific, monodisperse nano-molding of protein particles J. Am. Chem. Soc. 2008, 130 (16) 5438-9
35. Merkel, T. J.; Jones, S. W.; Herlihy, K. P.; Kersey, F. R.; Shields, A. R.; Napier, M.; Luft, J. C.; Wu, H.; Zamboni, W. C.; Wang, A. Z.; Bear, J. E.; DeSimone, J. M. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (2) 586-91
36. Merkel, T. J.; Chen, K.; Jones, S. W.; Pandya, A. A.; Tian, S.; Napier, M. E.; Zamboni, W. E.; Desimone, J. M. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles J. Controlled Release 2012, 162 (1) 37-44
37. Perry, J. L.; Reuter, K. G.; Kai, M. P.; Herlihy, K. P.; Jones, S. W.; Luft, J. C.; Napier, M.; Bear, J. E.; DeSimone, J. M. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics Nano Lett 2012, 12 (10) 5304-10
38. Garcia, A.; Mack, P.; Williams, S.; Fromen, C.; Shen, T.; Tully, J.; Pillai, J.; Kuehl, P.; Napier, M.; Desimone, J. M.; Maynor, B. W. Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications J. Drug Delivery 2012, 2012, 941243
39. Dunn, S. S.; Tian, S.; Blake, S.; Wang, J.; Galloway, A. L.; Murphy, A.; Pohlhaus, P. D.; Rolland, J. P.; Napier, M. E.; DeSimone, J. M. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing J. Am. Chem. Soc. 2012, 134 (17) 7423-30
40. Malone, R. W.; Felgner, P. L.; Verma, I. M. Cationic liposome-mediated RNA transfection Proc. Natl. Acad. Sci. U.S.A. 1989, 86 (16) 6077-81
41. Read, M. L.; Singh, S.; Ahmed, Z.; Stevenson, M.; Briggs, S. S.; Oupicky, D.; Barrett, L. B.; Spice, R.; Kendall, M.; Berry, M.; Preece, J. A.; Logan, A.; Seymour, L. W. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids Nucleic Acids Res. 2005, 33 (9) e86